Health and Fitness

FDA Approves Novel Preventive Treatment for Migraine in Adults

Aimovig
Aimovig, a new kind of migraine drug, is injected once a month. The medicine reduced the number of migraines in clinical studies reviewed by the Food and Drug Administration. (Source: Amgen/AP)
Silver Spring, Maryland—(ENEWSPF)—May 18, 2018
Contact: Sandy Walsh

The U.S. Food and Drug Administration (FDA) approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new…

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES